1.90Open1.84Pre Close53 Volume1.32K Open Interest11.00Strike Price8.33KTurnover0.00%IV1.23%PremiumJan 17, 2025Expiry Date1.17Intrinsic Value100Multiplier-1DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma12.81Leverage Ratio--Theta--Rho--Eff Leverage--Vega
CorMedix Stock Discussion
Until it wasn’t… Joe Todisco’s leadership, as CEO, troubles me.
CORMEDIX INC. ANNOUNCES PRELIMINARY FOURTH QUARTER 2024 RESULTS AND PROVIDES BUSINESS UPDATE - CorMedix | Prevention of cardiac, renal and infectious diseases
$72-78mm spending in 2025, “…largely driven by R&D,” they said?
“[Co...
Time to call it a day
No comment yet